{"id":"NCT01454063","sponsor":"Omeros Corporation","briefTitle":"Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification","officialTitle":"A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study of the Effect of OMS302 on Intraoperative Pupil Diameter and Early Postoperative Pain in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09","primaryCompletion":"2012-03","completion":"2012-03","firstPosted":"2011-10-18","resultsPosted":"2014-08-21","lastUpdate":"2014-08-21"},"enrollment":405,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Intraocular Lens Replacement"],"interventions":[{"type":"DRUG","name":"OMS302","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"OMS302","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the safety and efficacy of OMS302 (the study drug) for maintaining intraoperative mydriasis in individuals undergoing Intraocular Lens Replacement (ILR) surgery.","primaryOutcome":{"measure":"Mean Area-under-the-Curve (AUC) Analysis of Change From Baseline in Pupil Diameter (mm) During Surgery","timeFrame":"from surgery baseline (pre-incision) through surgery end (time of cortical clean-up/wound closure)","effectByArm":[{"arm":"OMS302","deltaMin":0.1,"sd":0.41},{"arm":"Placebo","deltaMin":-0.5,"sd":0.58}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":16,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":201},"commonTop":["eye pain","eye inflammation","anterior chamber inflammation","headache","intraocular pressure increased"]}}